PROSTATE-SPECIFIC ANTIGEN TESTING IN HYPOGONADISM: IMPLICATIONS FOR THE SAFETY OF TESTOSTERONE-REPLACEMENT THERAPY
โ Scribed by DUNCAN C. GOULD; MARK R. FENELEY; ROGER S. KIRBY
- Book ID
- 109052547
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 107 KB
- Volume
- 98
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Previous studies have suggested that serum prostate-specific antigen (PSA) levels are under androgenic influence, especially in patients with adenocarcinoma of the prostate. PSMA (prostate-specific membrane antigen) is thought to reflect hormonal or clonal resistance or an independence with respect
The characteristic sclerotic appearance of bone metastases from prostate cancer is unexplained but could involve excess peritumoural activity of osteoblast mitogens such as the insulin-like growth factors (IGFs). Since prostatic metastases are distinguished by androgen-dependent secretion of prostat